STAAR Surgical Announces Submission of Presbyopia Clinical Trial Data; Proprietary EDOF Collamer® Lens is Designed to Improve Near, Intermediate and Distance Vision
Go back to STAAR Surgical Announces Submission of Presbyopia Clinical Trial Data; Proprietary EDOF Collamer® Lens is Designed to Improve Near, Intermediate and Distance Vision| Staar Surgical Co (NASDAQ: STAA) | Delayed: 20.82 -0.42 (1.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.24 | 52 Week High | $10.95 | |||
| Open | $21.11 | 52 Week Low | $4.98 | |||
| Day High | $21.16 | P/E | N/A | |||
| Day Low | $20.47 | EPS | $-0.01 | |||
| Volume | 5,743,193 | |||||
